Numinus' Phase I clinical trial will evaluate safety/tolerance properties of its Psilocybe mushroom product.
Montana’s Crow Tribe Approves Adult-Use Cannabis Rules
The Montana-based Crow Tribe last week approved an ordinance to oversee its own cannabis cultivation and sales, and allow the tribe to benefit from the proceeds, the Associated Press reports.
Investors Forget About Gold At WORST Possible Time
As more and more traders experience "inflation fears", investors have FORGOTTEN the ultimate insurance for inflation: gold.
Drug Reform: Record (91%) American Support For Legalizing Medicinal Cannabis
U.S. support for legalizing cannabis for medicinal use has hit a new record-high: 91%. Strong bipartisan support. Next: psychedelic drugs.
Gold, silver up as bulls riding the price uptrend
Gold and silver prices are are higher in early U.S. trading Friday, supported by bullish outside markets on this day that include a lower U.S. dollar index and firmer crude oil prices.
Champignon Brands Announces Revocation of Cease Trade Orders
Champignon Brands has had its Cease Trade Order lifted and can resume trading on the CSE effective April 23, 2021 (symbol: SHRM).
MindMed To Commence Trading on Nasdaq
MindMed Inc (CAN:MMED / US:MMEDF) has received approval to commence trading on the NASDAQ starting April 27th. Symbol: MNMD.
METALS-Copper up with equities, but virus surge limits gains
Copper prices firmed on Wednesday alongside a rebound in equities and a weaker dollar, though investor fears over rising coronavirus cases limited gains.
(WATCH) - Cobalt, nickel battery use rises as electric sports cars gain popularity
Despite a big drop from December’s blowout, largely due to seasonal factors, the February 2021 MINING.COM EV Metal Index, which tracks the value of battery metals in newly registered passenger EVs (including hybrids) around the world, still ranks as the fourth best month on record.
Countdown To The atai IPO Begins: atai Files For $100m IPO Financing
With atai Life Sciences filing for a $100 million IPO financing, the countdown to IPO day has begun.
Mined gold supply still not keeping up with demand
2020 was a mixed bag for gold producers. On the one hand covid-19 forced many to temporarily halt operations, due to government-imposed lockdowns.
Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the Treatment of Depression and Addiction
Cybin has successfully demonstrated proof of concept for two new drug candidates in internal testing as it moves toward IND status.
